Analystreport

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) was given a new $24.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com